Impact of CardiolRxTM on Recurrent Pericarditis: An open label Pilot Study

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-507452-77-00

Acronym

Cardiol 100-004

Enrollment

Registered

2024-01-05

Start date

Unknown

Completion date

2024-02-20

Last updated

2024-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recurrent Pericarditis

None listed

Sex/Gender

All

Age

18 Years to No maximum

France

None listed

Source: EU CTIS · Data processed: Feb 4, 2026